vs
Side-by-side financial comparison of KB HOME (KBH) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
KB HOME is the larger business by last-quarter revenue ($1.7B vs $1.1B, roughly 1.5× PERRIGO Co plc). KB HOME runs the higher net margin — 6.0% vs -127.8%, a 133.8% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -15.3%). KB HOME produced more free cash flow last quarter ($290.1M vs $148.6M). Over the past eight quarters, KB HOME's revenue compounded faster (7.4% CAGR vs 1.3%).
KB Home is an American homebuilding company founded in 1957 as Kaufman & Broad in Detroit, Michigan. It was the first company to be traded on the New York Stock Exchange as a home builder. Its headquarters are in Los Angeles, California.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
KBH vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.1B |
| Net Profit | $101.5M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | — | -116.0% |
| Net Margin | 6.0% | -127.8% |
| Revenue YoY | -15.3% | -2.5% |
| Net Profit YoY | -46.7% | -3093.9% |
| EPS (diluted) | $1.55 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.7B | $1.1B | ||
| Q3 25 | $1.6B | $1.0B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.4B | $1.0B | ||
| Q4 24 | $2.0B | $1.1B | ||
| Q3 24 | $1.8B | $1.1B | ||
| Q2 24 | $1.7B | $1.1B | ||
| Q1 24 | $1.5B | $1.1B |
| Q4 25 | $101.5M | $-1.4B | ||
| Q3 25 | $109.8M | $7.5M | ||
| Q2 25 | $107.9M | $-8.4M | ||
| Q1 25 | $109.6M | $-6.4M | ||
| Q4 24 | $190.6M | $-44.4M | ||
| Q3 24 | $157.3M | $-21.0M | ||
| Q2 24 | $168.4M | $-108.4M | ||
| Q1 24 | $138.7M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | — | -116.0% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 10.0% | ||
| Q3 24 | — | 7.4% | ||
| Q2 24 | — | -2.5% | ||
| Q1 24 | — | -5.1% |
| Q4 25 | 6.0% | -127.8% | ||
| Q3 25 | 6.8% | 0.7% | ||
| Q2 25 | 7.1% | -0.8% | ||
| Q1 25 | 7.9% | -0.6% | ||
| Q4 24 | 9.5% | -3.9% | ||
| Q3 24 | 9.0% | -1.9% | ||
| Q2 24 | 9.9% | -10.2% | ||
| Q1 24 | 9.4% | 0.2% |
| Q4 25 | $1.55 | $-10.23 | ||
| Q3 25 | $1.61 | $0.05 | ||
| Q2 25 | $1.50 | $-0.06 | ||
| Q1 25 | $1.49 | $-0.05 | ||
| Q4 24 | $2.50 | $-0.32 | ||
| Q3 24 | $2.04 | $-0.15 | ||
| Q2 24 | $2.15 | $-0.79 | ||
| Q1 24 | $1.76 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.9B | $2.9B |
| Total Assets | $6.7B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $432.1M | ||
| Q2 25 | — | $454.2M | ||
| Q1 25 | — | $409.9M | ||
| Q4 24 | — | $558.8M | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $542.8M | ||
| Q1 24 | — | $658.5M |
| Q4 25 | $3.9B | $2.9B | ||
| Q3 25 | $3.9B | $4.4B | ||
| Q2 25 | $4.0B | $4.5B | ||
| Q1 25 | $4.1B | $4.4B | ||
| Q4 24 | $4.1B | $4.3B | ||
| Q3 24 | $4.0B | $4.6B | ||
| Q2 24 | $4.0B | $4.5B | ||
| Q1 24 | $3.9B | $4.7B |
| Q4 25 | $6.7B | $8.5B | ||
| Q3 25 | $7.0B | $10.1B | ||
| Q2 25 | $7.0B | $10.1B | ||
| Q1 25 | $7.0B | $9.8B | ||
| Q4 24 | $6.9B | $9.6B | ||
| Q3 24 | $6.8B | $11.2B | ||
| Q2 24 | $6.8B | $10.4B | ||
| Q1 24 | $6.7B | $10.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $303.8M | $175.4M |
| Free Cash FlowOCF − Capex | $290.1M | $148.6M |
| FCF MarginFCF / Revenue | 17.1% | 13.4% |
| Capex IntensityCapex / Revenue | 0.8% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | $287.3M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $303.8M | $175.4M | ||
| Q3 25 | $197.7M | $51.7M | ||
| Q2 25 | $168.4M | $75.9M | ||
| Q1 25 | $-334.3M | $-64.5M | ||
| Q4 24 | $362.6M | $312.6M | ||
| Q3 24 | $-89.9M | $42.2M | ||
| Q2 24 | $61.5M | $9.5M | ||
| Q1 24 | $28.5M | $-1.4M |
| Q4 25 | $290.1M | $148.6M | ||
| Q3 25 | $185.8M | $29.8M | ||
| Q2 25 | $156.9M | $56.7M | ||
| Q1 25 | $-345.5M | $-90.0M | ||
| Q4 24 | $352.6M | $274.9M | ||
| Q3 24 | $-99.4M | $15.1M | ||
| Q2 24 | $51.2M | $-18.9M | ||
| Q1 24 | $19.1M | $-26.5M |
| Q4 25 | 17.1% | 13.4% | ||
| Q3 25 | 11.5% | 2.9% | ||
| Q2 25 | 10.3% | 5.4% | ||
| Q1 25 | -24.8% | -8.6% | ||
| Q4 24 | 17.6% | 24.2% | ||
| Q3 24 | -5.7% | 1.4% | ||
| Q2 24 | 3.0% | -1.8% | ||
| Q1 24 | 1.3% | -2.4% |
| Q4 25 | 0.8% | 2.4% | ||
| Q3 25 | 0.7% | 2.1% | ||
| Q2 25 | 0.8% | 1.8% | ||
| Q1 25 | 0.8% | 2.4% | ||
| Q4 24 | 0.5% | 3.3% | ||
| Q3 24 | 0.5% | 2.5% | ||
| Q2 24 | 0.6% | 2.7% | ||
| Q1 24 | 0.6% | 2.3% |
| Q4 25 | 2.99× | — | ||
| Q3 25 | 1.80× | 6.89× | ||
| Q2 25 | 1.56× | — | ||
| Q1 25 | -3.05× | — | ||
| Q4 24 | 1.90× | — | ||
| Q3 24 | -0.57× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 0.21× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KBH
| Home Building | $1.7B | 99% |
| Financial Service | $8.7M | 1% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
